Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 5Multiple Myeloma 3Leukemia 3Burkitt Lymphoma 3Neoplasms 2Myelodysplastic Syndromes 2Lymphoma, T-Cell, Peripheral 2Lymphoma, Non-Hodgkin 2Lymphoma, Large B-Cell, Diffuse 2Leukemia, Myeloid, Acute 2Solid Tumors 1Solid Tumor 1Rhabdomyosarcoma 1Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms, Plasma Cell 1Neoplasms by Site 1Nasopharyngeal Carcinoma 1Melanoma 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma, B-Cell 1Lymphoma 1Leukemia, Myelomonocytic, Juvenile 1Hodgkin Disease 1Hematopoietic System--Cancer 1Hematologic Neoplasms 1Hematologic Diseases 1Graft vs Host Disease 1Fibrosis Of Extraocular Muscles, Congenital, 3A, with or without Extraocular Involvement 1Disease Progression 1

Interventions

Paclitaxel 1Gemcitabine 1Doxorubicin 1Cyclophosphamide 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Fibrosis Of Extraocular Muscles, Congenital, 3A, with or without Extraocular Involvement × Cyclophosphamide × Clear all
NCT06531447 2024-08-01

First-line Gemcitabine Plus Cisplatin in Locally Advanced (IIIC Stage) Breast Cancer Patients

The National Center of Oncology, Azerbaijan

Phase 2 Active not recruiting
200 enrolled
Breast

Fibrosis Of Extraocular Muscles, Congenital, 3A, with or without Extraocular Involvement, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡